1.
Bioorg Med Chem Lett
; 20(2): 576-80, 2010 Jan 15.
Artículo
en Inglés
| MEDLINE
| ID: mdl-20005097
RESUMEN
Potent, highly selective and orally-bioavailable MMP-13 inhibitors have been identified based upon a (pyridin-4-yl)-2H-tetrazole scaffold. Co-crystal structure analysis revealed that the inhibitors bind at the S(1)(') active site pocket and are not ligands for the catalytic zinc atom. Compound 29b demonstrated reduction of cartilage degradation biomarker (TIINE) levels associated with cartilage protection in a preclinical rat osteoarthritis model.